Viet Nam Pharmaceutical - JSC (HSTC:DVN) Marketable Securities: ₫653,189 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HSTC:DVN Viet Nam Pharmaceutical Corp - JSC HSTC:DVN
80 GF Score
Price ₫18,700.00
GF Value ₫22,082.59
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Viet Nam Pharmaceutical - JSC Marketable Securities?

Viet Nam Pharmaceutical - JSC HSTC:DVN -1.58% 80 Marketable Securities is ₫653,189 Mil as of Mar. 2026. GuruFocus rates HSTC:DVN with a GF Score™ of 80/100 and a GF Value™ of ₫22,082.59 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Viet Nam Pharmaceutical - JSC's Marketable Securities for the quarter that ended in Mar. 2026 was ₫653,189 Mil.

Viet Nam Pharmaceutical - JSC's annual Marketable Securities declined from Dec. 2023 (₫923,250 Mil) to Dec. 2024 (₫755,670 Mil) and declined from Dec. 2024 (₫755,670 Mil) to Dec. 2025 (₫644,080 Mil).

Viet Nam Pharmaceutical - JSC  (HSTC:DVN) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Viet Nam Pharmaceutical - JSC Marketable Securities Related Terms

Viet Nam Pharmaceutical - JSC Marketable Securities Historical Data

* Premium members only.

The historical data trend for Viet Nam Pharmaceutical - JSC's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Viet Nam Pharmaceutical - JSC Marketable Securities Chart

Viet Nam Pharmaceutical - JSC Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial 673,050.00 634,550.00 923,250.00 755,670.00 644,080.00

Viet Nam Pharmaceutical - JSC Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 975,870.00 763,610.00 621,410.00 644,080.00 653,189.48
HSTC:DVN
80GF Score
Viet Nam Pharmaceutical Corp - JSC HSTC:DVN
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Viet Nam Pharmaceutical - JSC Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ₫653,189 Mil mean?
Viet Nam Pharmaceutical - JSC (HSTC:DVN) has a Marketable Securities of ₫653,189 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Viet Nam Pharmaceutical - JSC and its competitors.
Is Viet Nam Pharmaceutical - JSC's Marketable Securities too high?
Viet Nam Pharmaceutical - JSC's current Marketable Securities is ₫653,189 Mil. Overall, Viet Nam Pharmaceutical - JSC has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Viet Nam Pharmaceutical - JSC's Marketable Securities compare to ZTS?
Viet Nam Pharmaceutical - JSC's Marketable Securities of ₫653,189 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Drug Manufacturers company?
A good Marketable Securities depends on the Drug Manufacturers industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Viet Nam Pharmaceutical - JSC and its competitors. Viet Nam Pharmaceutical - JSC's current Marketable Securities is ₫653,189 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viet Nam Pharmaceutical - JSC stock overvalued right now?
Based on GuruFocus' analysis, Viet Nam Pharmaceutical - JSC (HSTC:DVN) is currently considered Modestly Undervalued. The stock's GF Value™ is ₫22,082.59, compared to a current price of ₫18,700.00 — trading 15.3% below its estimated fair value. The current Marketable Securities is ₫653,189 Mil. Viet Nam Pharmaceutical - JSC's overall GF Score™ is 80/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Viet Nam Pharmaceutical - JSC (HSTC:DVN), the current Marketable Securities is ₫653,189 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Viet Nam Pharmaceutical - JSC (HSTC:DVN) Overvalued in 2026?

Based on GuruFocus' analysis, Viet Nam Pharmaceutical - JSC stock appears to be undervalued. The current stock price of ₫18,700.00 is trading 15.3% below its estimated GF Value™ of ₫22,082.59. GuruFocus considers Viet Nam Pharmaceutical - JSC to be Modestly Undervalued.

Key valuation signals for HSTC:DVN:

  • Marketable Securities: ₫653,189 Mil
  • GF Value™: ₫22,082.59 vs. price of ₫18,700.00 (15.3% below fair value)
  • GF Score™: 80/100 with 5 warning signs

No single metric tells the full story. See the HSTC:DVN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Viet Nam Pharmaceutical - JSC Business Description

Address 12 Ngo Tat To, Van Mieu Ward, Dong Da District, Hanoi, VNM
Viet Nam Pharmaceutical Corp - JSC is engaged in the manufacturing of drugs. The company provides testing services for drugs and medicinal ingredients.
80GF Score

Get the complete analysis for HSTC:DVN

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫18,700.00
Price
₫22,082.59
GF Value